Through a dedicated portfolio evaluation process & thereby leveraging our R&D as well as Manufacturing capabilities, we're able to offer a value-added oral solid dosage form.
At Inventia, we believe in leading through innovations in drug delivery. Our aim is to make medicines more patient-friendly and ensure compliance to therapy, which is a major concern in health management and thus improve the overall health conditions. Consequently, we believe that significant progress is achieved through not just formal planning but also through constant innovation.
Our company was incorporated as a private limited company
Our company filed process patent for the anti-diabetic molecule
Our R&D Centre at Thane received approval by Department of Science and Technology, Government of India
Our company was granted four patents and finalized two technology transfers with overseas and Indian pharmaceuticals
Our manufacturing facility at Ambernath operationalized and received WHO GMP certification
Our Ambernath facility received an approval by USFDA, Korean FDA
Our Ambernath facility received an approval by ANIVSA
Our Ambernath facility received an approval by UKMHRA
Our company filed 13 ANDA's
Our Ambernath facility received good manufacturing practice certificate by INVIMA, Columbia.
Our Ambernath facility received a product approval in Europe.
Our Ambernath facility received good manufacturing practice certificate by COFEPRIS, Mexico
Our Ambernath facility received good manufacturing practice certificate by Jordan FDA
Our Ambernath facility received 1st product approval in UK.